Form 8-K - Current report:
SEC Accession No. 0001654954-17-005627
Filing Date
2017-06-16
Accepted
2017-06-16 08:30:32
Documents
4
Period of Report
2017-06-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v061617_8k.htm 8-K 32848
2 EXHIBIT 99.1 v061417_ex991.htm EX-99.1 19361
3 EXHIBIT 99.2 v061517_ex992.htm EX-99.2 18793
4 EXHIBIT 99.3 v061617_ex993.htm EX-99.3 41622
  Complete submission text file 0001654954-17-005627.txt   114021
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 17914826
SIC: 2834 Pharmaceutical Preparations